Ben Standeven

Ben Standeven has a diverse work experience spanning different roles in various companies. Ben is currently a Co-Founder at Global Innovative Health since January 2023. Prior to that, they worked as a Consultant at Apheli Health starting from July 2022. Ben also served as a Fractional Chief Commercial Officer (CCO) at Written Medicine, the Commercial Lead at NeuroResponse, and the Director - Asia-Pacific at EIDO Healthcare | Asia-Pacific.

Ben has a long history with EIDO Healthcare, where they held multiple roles from 2008 to 2022. These roles included Director Of International Development, International Business Development & National Account Manager, National Account Manager, and Account Manager. Throughout their career, Ben has been involved in sales, new business development, national account management, and business marketing activities. Ben has experience in generating new business sales both nationally and internationally, as well as managing accounts for NHS Trusts, private hospitals, and private hospital groups in the UK and Ireland. Ben has also managed client relationships, identified sales opportunities, and established budgets. Ben has a strong belief in the products they sell, which help hospitals, hospital staff, and patients in the Acute Surgery markets.

Ben Standeven earned their BA (Hons) in Marketing from Birmingham City University from 2005 to 2008. Ben is currently pursuing an Executive MBA from Nottingham Business School, Nottingham Trent University, which they started in 2020 and is expected to complete in 2023.